Armata Pharmaceuticals Inc ARMP:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 4:00 PM EDT
4.07quote price arrow down-0.03 (-0.73%)
Volume
35,715
52 week range
1.07 - 5.26
Loading...
  • Open4.10
  • Day High4.18
  • Day Low3.85
  • Prev Close4.10
  • 52 Week High5.26
  • 52 Week High Date08/14/23
  • 52 Week Low1.07
  • 52 Week Low Date07/17/23

Key Stats

  • Market Cap147.125M
  • Shares Out36.15M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • YTD % Change29.01

KEY STATS

  • Open4.10
  • Day High4.18
  • Day Low3.85
  • Prev Close4.10
  • 52 Week High5.26
  • 52 Week High Date08/14/23
  • 52 Week Low1.07
  • 52 Week Low Date07/17/23
  • Market Cap147.125M
  • Shares Out36.15M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • YTD % Change29.01

RATIOS/PROFITABILITY

  • EPS (TTM)-1.91
  • P/E (TTM)-2.13
  • Fwd P/E (NTM)-3.10
  • EBITDA (TTM)-39.911M
  • ROE (TTM)-3,439.35%
  • Revenue (TTM)4.529M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,524.51%
  • Debt To Equity (MRQ)-256.69%

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Armata Pharmaceuticals Inc

 

Profile

MORE
Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its bacteriophage-based technology. It has developed care therapies, including the multidrug-resistant or superbug strains of bacteria. The Company is a developer of phage therapeutics, which are positioned to address the...
Deborah Birx M.D.
Chief Executive Officer, Director
Richard Rychlik
Principal Financial Officer
Address
5005 Mcconnell Ave
Los Angeles, CA
90066
United States

Top Peers

SYMBOLLASTCHG%CHG
NGM
NGM Biopharmaceuticals Inc
1.59-0.03-1.85%
COYA
Coya Therapeutics Inc
9.92+0.27+2.80%
CRVO
CervoMed Inc
23.30+3.68+18.76%
LIFE
aTyr Pharma Inc
1.95-0.05-2.50%
ACRV
Acrivon Therapeutics Inc
7.15+0.69+10.60%